feed,title,long_url,short_url
Benzinga,Oblique Therapeutics and Targovax Enter Collaboration to Target Mutant RAS Cancers by Combining Their ONCOS and Abiprotâ„¢ Platforms,https://www.benzinga.com/pressreleases/20/06/n16422415/oblique-therapeutics-and-targovax-enter-collaboration-to-target-mutant-ras-cancers-by-combining-th,https://j.mp/2CQK5kM
